Atlas Trials

Bone Effects of Teriparatide Following Alendronate

Clinical trial NCT00191893 · COMPLETED

Trial details

NCT number
NCT00191893
Sponsor
Eli Lilly and Company
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Osteoporosis
Start date
2003-09-01
Enrollment
66

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.